Heart Failure Flashcards
Primary signs/sxs of HF
tachycardia, decreased exercise tolerance, SOB, cardiomegaly, peripheral/pulmonary edema
Compensatory responses in HF
increased SNS activity, increased preload, vasoconstriction, ventricular hypertrophy/remodeling
What are the 2 goals of treatment of HF
- reduce sxs and slow progression as much as possible
- manage acute episodes of decompensated failure
Pharmacological tx for stage C HF with reduced EF?
Renin-Angiotension System Inhibition with ACE-I or ARB or ARNI
ARNIs should not be given to pts who…
are taking an ACE-I
those with hx of angioedema
Ivabradine can be beneficial to which pts?
Can reduce HF hospitalizations for pts with symptomatic stable chronic HFrEF who are receiving max dose of BB and are in NSR
What is recommended in additional to standard HF therapy in African American pts?
venodilator: hydralazine Isosorbide Dinitrate
MOA of Ivabradine
prolongs diastolic time by selectively and specifically inhibiting the Icurrent within the HCN channel, reducing HR
Side effects of Ivabradine
dizziness, fatigue
less common: increase BP, visual light disturbances, Afib
contraindications for Ivabradine
acute decompensated HF, BO <90/50, sick sinus syndrome, AA block, severe hepatic impairment, PPM dependent
Avoid use of Ivabradine with…
strong CYP3A4 inhibitors
Define systolic dysfunction
reduced mechanical pumping action and reduced EF
Define diastolic dysfunction
stiffening and loss of adequate relaxation —> reduction in filling and CO (EF may be norm)
What are the 4 stages in the ACC/AHA heart failure staging system?
Stage A: Pt at high risk for developing HF
Stage B: Pt with structural heart disease but no HF
Stage C: Pt with structural heart disease + current or hx of HF sxs
Stage D: refractory HF requiring specialized interventions
Therapies used in chronic systolic HF
diuretics, aldosterone antagonist, ACE-I, ARBs, BB, cardiac glycosides, vasodilators, resynchronization/CCV
Therapies used in acute HF
diuretics, vasodilators, beta agonists, bipyridines, natriuretic peptide, LVAD
What lab marker can be used to predict the prognosis and classification of HF?
BNP
Na/K ATPase inhibitors- example? MOA?
Digoxin
increases Ca, increase cardiac contractility (Chronic HF)
Renal sodium transporter inhibitor- example? MOA?
Furosemide, Spironolactone, other diuretics
reduce preload and afterload (acute and chronic HF)
ACE-I: example? MOA?
Lisinopril
reduce preload and afterload, reduce remodeling
Vasodilators: example? MOA?
Nitroprusside, Nitroglycerine
reduce preload and afterload
acute HF
Phosphodiesterase inhibitors: example? MOA?
Milrinone
vasodilation, increase contractility (acute HF)
Natriuretic peptide: example? MOA?
Nesiritide
vasodilation reduces preload and afterload; some diuretic effect (acute HF)
HCN:example? MOA?
Ivabradine
slows HR
(chronic stable worsening HF)
Where in the nephron does Furosemide act?
loop diuretic
decreases NaCl and KCl reabsorption in the thick ascending loop of henle
Loop diuretic (Furosemide) toxicities?
hypovolemia, hypokalemia, orthostatic hypotension, ototoxicity
avoid in those with sulfa allergy
What will happen if you give a higher dose of Furosemide than what is included in the usual range (20-160mg)?
it is not likely that there will be an additional response.
HCTZ MOA?
decreases NaCL reabsorption in the distal convoluted tubule
same effect Furosemide but not as strong
When should you prescribe HCTZ?
in mild chronic HF, mild-mod HTN, hypercalciuria